COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 270: Articles 2691-2700  | Next

Screening Peptide Drug Candidates to Neutralize Whole Viral Agents : A Case study with SARS-CoV-2 Virus
Ozcelik, C. E., Araz, C. Z., Yilmaz, O., Gulyuz, S., Ozkul, A., Seker, U. O. S.
10.1101/2023.10.22.563490 — Posted: 2023-10-23
A bioactive peptide from the pearl has dual roles in resisting SARS-CoV-2 infection and its complications
Liu, X., Wang, Y., Yin, Z., Wang, Q., Chen, X., Li, B., Yao, L., Zhang, Z., Zhang, R.
10.1101/2023.10.23.563427 — Posted: 2023-10-23
Perceptions and responses to COVID-19 through wastewater surveillance information and online search behavior: A randomized controlled trial
Murakami, M., Nomura, S., Ando, H., Kitajima, M.
10.1101/2023.10.20.23297297 — Posted: 2023-10-21
Factors Influencing the Trajectory of COVID-19 Evolution: A Longitudinal Study of 12 Asian Countries
He, X., Liu, H., Zeng, F., Gao, W.
10.1101/2023.10.20.23297319 — Posted: 2023-10-21
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months
Karkanitsa, M., Li, Y., Valenti, S., Spathies, J., Kelly, S., Yee, L., Croker, J. A., Wang, J., Lucia Alfonso, A., Faust, M., Mehalko, J., Drew, M., Denson, J.-P., Putman, Z., Fathi, P., Ngo, T. B., Siripong, N., Ann Baus, H., Petersen, B., Ford, E. W., Sundaresan, V., Sundaresan, V., Josyula, A., Han, A., Giurgea, L. T., Angela Rosas, L., Bean, R., Athota, R., Czajkowski, L., Klump-Thomas, C., Cervantes-Medina, A., Gouzoulis, M., Reed, S., Graubard, B., Hall, M. D., Kalish, H., Esposito, D., Kimberly, R. P., Reis, S., Sadtler, K., Memoli, M. J.
10.1101/2023.10.20.23297329 — Posted: 2023-10-21
Is Recovery Just the Beginning? Persistent Symptoms and Health and Performance Deterioration in Post-COVID-19, non-hospitalised University Students - A Cross-Sectional Study
Latifi, A., Flegr, J.
10.1101/2023.10.20.23297203 — Posted: 2023-10-21
Postacute Sequelae SARS-CoV-2 Infection by Vaccination Status: A Six-Month Latent Class Analysis
Sun, X., DeShazo, J. P., Anatale-Tardiff, L., Di Fusco, M., Allen, K. E., Porter, T. M., Coetzer, H., Lopez, S. M. C., Puzniak, L., Cappelleri, J. C.
10.1101/2023.10.20.23297332 — Posted: 2023-10-21
Reduced risk of SARS-CoV-2 infection among household contacts with recent vaccination and past COVID-19 infection: results from two multi-site case-ascertained household transmission studies
Rolfes, M. A., Talbot, H. K., Morrissey, K. G., Stockwell, M. S., Maldonado, Y., McLean, H. Q., Lutrick, K., Bowman, N. M., Rao, S., Izurieta, H. S., Zhu, Y., Chappell, J., Battan-Wraith, S., Merrill, L. S., McLaren, S. H., Sano, E., Biddle, J. E., Johnson, S., Salvatore, P. P., Smith-Jeffcoat, S. E., Asturias, E., Lin, J., Ellingson, K. D., Belongia, E. A., Olivo, V., Mellis, A. M., Grijalva, G. G., Respiratory Virus Transmission Network Study Group
10.1101/2023.10.20.23297317 — Posted: 2023-10-21
Assessment of Sociodemographic Factors Associated with Time to Self-reported COVID-19 Infection Among a Large Multi-Center Prospective Cohort Population in the Southeastern United States
Beron, A. J., Yukich, J. O., Berry, A. A., Correa, A., Keating, J., Bott, M., Wierzba, T. F., Weintraub, W. S., Friedman-Klabanoff, D. J., Mongraw-Chaffin, M., Gibbs, M. A., Taylor, Y. J., Kissinger, P. J., Hayes, D. V., Schieffelin, J. S., Burke, B., Oberhelman, R. A.
10.1101/2023.10.20.23297306 — Posted: 2023-10-21
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
Tsujino, S., Deguchi, S., Nomai, T., Padilla-Blanco, M., Plianchaisuk, A., Wang, L., Begum, M. M., Uriu, K., Mizuma, K., Nao, N., Kojima, I., Tsubo, T., Li, J., Matsumura, Y., Nagao, M., Oda, Y., Tsuda, M., Anraku, Y., Kita, S., Yajima, H., Tabata, K., Guo, Z., Hinay, A. A., Yoshimatsu, K., Yamamoto, Y., Nagamoto, Y., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Nasser, H., Jonathan, M., Putri, O., Kim, Y., Chen, L., Suzuki, R., Tamura, T., Maenaka, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Irie, T., Matsuno, K., Tanaka, S., Ito, J., Ikeda, T., Takayama, K., Zahradnik, J., Hashiguchi, T., Fukuhara, T., Sato, K.
10.1101/2023.10.19.563209 — Posted: 2023-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).